Tristel Share Discussion Threads

[z1co] 26/2/2024 16:21

Some taking profits which always happens but the price will be much by the time the company issues it's full year trading update in July which will no doubt very strong and AHEAD of expectations.

[z1co] 26/2/2024 16:14

CEO ,

"Looking forward, we expect to make our second FDA submission, a 510(k) for Tristel OPH, our ophthalmic device high level disinfectant, in time for an approval by the end of 2024. Post period end, all reviews under both UK and EU Medical Device Regulations for Tank and Capsule, the newest additions to the Cache range, have been successfully concluded and a positive recommendation for UKCA and MDR certification has been made. This enables us to expand into the largely untapped sporicidal surface disinfection market".

[z1co] 26/2/2024 16:12

The company will most likely hike it's full year dividend by 50% or maybe even higher.

CEO ,

"This six-month period represents the highest sales and profit performance that the Company has experienced in its thirty-year history, including during the early COVID era when demand for our products was unprecedented.

[z1co] 26/2/2024 16:05

The management today have increased the interim dividend by 100% to 5.24p , this is a clear sign that they are very confident that the company will keep growing it's revenue , PBT , EPS and also be very cash generative.

Very rare that a company increases it's dividend this much unless they know that their business will trade very strongly and ahead of expectations for the foreseeable future.

In the past companies that have significantly increased their dividends , their share price has also performed very strongly.

[james188] 26/2/2024 15:35

I suspect that Liz Dixon is a likely candidate for the CEO role and so the current CEO deliberately stepped back during the presentation/Q&A. Being the lead presenter takes a bit of getting used to.

I was interested in the significant increase in staff numbers (27 more people into sales, marketing and distribution). That compares to 90 people in that category at the end of FY 2023 and 78 people at the end of FY 2022. I regard that as good news. This is the time for the company to motor.

[74tom] 26/2/2024 15:10

Presentation certainly didn't set the world on fire, it felt a bit as though the CFO was hung out to dry by the CEO, who sat next to her but only answered one question (and the answer was by far the most comprehensive & confident of the meeting). Unsure why the outgoing CEO felt the need to be a bystander, especially after such positive results.

Valuation looks challenging to me, (even assuming for a full year beat and 14p EPS, they are on 33x FY24 P/E) especially if they want to be treated as a growth company but insist on paying out a material proportion of their EPS as a dividend. Wouldn't shareholders prefer them to invest in their R&D resource so they can get products to market faster?

Nanosonics also reported today on the ASX , missed expectations & shares fell 15% to multi year lows. Their revenues are double TSTL, but due to them spending ~£16m PA on R&D their reported PBT fell to below TSTL. Market cap down to £410m with £60m cash, so on an EV/Sales basis they are now around 20% cheaper than TSTL vs level pegging on Friday. Quite a divergence, which is understandable based on today's results alone, but seems to underestimate their installed base on 30k machines in the US.

Either way, a quality company & long term success story, but based on today's call I'd be concerned that the outgoing CEO will be difficult to replace and hence the 34x rating offers next to no margin of safety.

[z1co] 26/2/2024 12:12

Nice 15,000 buy @ £4.90

[wad collector] 26/2/2024 10:43

Nice to see something blue in the portfolio this morning. I like the £10.8M cash pile and the doubling of the dividend particularly!

[z1co] 26/2/2024 08:46

Bought a few after the expected pull back.

These were excellent results well ahead of expectations.When a company doubles it's dividend it usually means they are very confident that trading will remain very good for the foreseeable future.

Waiting for the price to settle down before adding more.

[gre] 26/2/2024 08:40

Fantastic results even before US growth kicks in. Also expecting big increase in Cache sales in UK and Europe now that the Tank and Capsule certification imminent.

Happy days.

[paulisi] 26/2/2024 08:06

Decent results. Expect further growth on a high margin once US sales kick in.Nice upward movement in share price this morning.

[zimbtrader] 26/2/2024 07:58

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products utilising proprietary chlorine dioxide technology, announces its interim results for the six months to 31 December 2023, exceeding internal growth targets by delivering 20% revenue growth and 44% growth in pre-tax profits. The Company also announces a doubling of its interim dividend payment.The Company's core business is the sale to hospitals of its proprietary chlorine dioxide chemistry used for the decontamination of medical devices under the Tristel brand, and for the sporicidal disinfection of environmental surfaces under the Cache brand. Financial highlights·      Revenue up 20% to a record £20.9m (2022: £17.5m)·      Overseas sales up 13% to £12.7m (2022: £11.2m)·      Reported EBITDA up 21% to £4.7m (2022: £3.9m)·      Adjusted* EBITDA up 18% to £5.4m (2022: £4.6m)·      Reported profit before tax up 44% to £3.4m (2022: £2.4m)·      Adjusted* profit before tax up 34% to £4.1m (2022: £3.1m)·      Reported EPS up 104% to 6.50p (2022: 3.19p)·      Adjusted* EPS of 8.68p up 87% (2022: 4.65p)·      Doubling of interim dividend to 5.24p per share (2022: 2.62p)·      No debt and cash of £10.8m (2022: £8.4m)*Adjusted for share-based payments of £0.7m (2022: £0.7m)Operational highlights·      First manufacture and launch of Tristel ULT into the United States ultrasound market·      Approval of Tristel ULT by Health Canada post-period end·      UK & EU Medical Device Regulation reviews of Cache Tank and Capsule successfully concluded and positive recommendation for UKCA and MDR certification made post-period end 

[zimbtrader] 26/2/2024 07:56

The Board is recommending an interim dividend of 5.24 pence (2022: 2.62 pence) to be paid on 12 April 2024. The associated ex-dividend date will be 21 March 2024 with a record date of 22 March 2024.

[zimbtrader] 26/2/2024 07:53

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products utilising proprietary chlorine dioxide technology, announces its interim results for the six months to 31 December 2023, exceeding internal growth targets by delivering 20% revenue growth and 44% growth in pre-tax profits

[zimbtrader] 26/2/2024 07:51

Anyone seen the results this morning. Seems ADVFN are rushing to link them on news.

[james188] 31/1/2024 21:55

The main backers are French. It sells outside the US in various locations - including the UK. It markets itself very aggressively as a superior product to Tristel. I continue to believe that Tristel needs to develop a response, based upon scientific evidence.

[apad] 31/1/2024 20:49

Surely you can't shine a light into curved tube?

I'm not at all sure that going on the offensive would do anything other than giving the competitor some free publicity.

james188, how come it is selling products if it doesn't have FDA approval?

apad

[james188] 31/1/2024 20:27

This is not new. The lead product is Chronos - developed by Germitec. It is well financed and has been seeking FDA approval for over one year. I consider it a more significant potential threat than Trophon. I specifically raised this point with the company at the results presentation last Autumn. I was told that there are material problems with the product and that TSTL is relaxed about the threat and viewed the very direct attack it makes as a compliment. My response was that the company needs to go on the offensive and point out why it has the superior product.

[apad] 31/1/2024 17:52

Interesting. UV light has been around for ages as a disinfectant. I wonder what is special about this and whether UV disinfects crevices.
apad

[piedro] 31/1/2024 17:06

OMG ...

UV Smart D45.
High level disinfection of ultrasound probes using UV-C light.

Automated. Fast.
No Consumables.
Designed for healthcare teams prioritizing patient safety and workflow efficiency, the UV Smart D45 provides fast, automated, and traceable disinfection for ultrasound probes.

Its instant high-level disinfection process, free from consumables, helps mitigate the risk of infections, including STDs and HPV spread, ensuring both infection control and sustainability.

[11_percent] 23/1/2024 10:29

Very volatile share.....that's one hell of a gap up.

[petewy] 23/1/2024 09:14

Thumbs up from Canada

[petewy] 21/1/2024 13:06

Good article by Richard Beddard for ii.
hxxps://www.ii.co.uk/analysis-commentary/richard-beddard-can-small-uk-firm-make-it-big-america-ii530485?

[wad collector] 11/1/2024 16:25

Well spotted petewy, I suppose there is no reason a share deal needs to be an open market transaction?